These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 22491822)

  • 1. Boron uptake in normal melanocytes and melanoma cells and boron biodistribution study in mice bearing B16F10 melanoma for boron neutron capture therapy.
    Faião-Flores F; Coelho PR; Arruda-Neto JD; Camillo MA; Maria-Engler SS; Rici RE; Sarkis JE; Maria DA
    Radiat Environ Biophys; 2012 Aug; 51(3):319-29. PubMed ID: 22491822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of boron neutron capture therapy for melanotic and amelanotic melanoma transplanted into mouse brain.
    Iwakura M; Kondoh H; Hiratsuka J; Ehara K; Tamaki N; Mishima Y
    Pigment Cell Res; 2002 Feb; 15(1):67-75. PubMed ID: 11837459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell cycle arrest, extracellular matrix changes and intrinsic apoptosis in human melanoma cells are induced by Boron Neutron Capture Therapy.
    Faião-Flores F; Coelho PR; Arruda-Neto JD; Maria-Engler SS; Maria DA
    Toxicol In Vitro; 2013 Jun; 27(4):1196-204. PubMed ID: 23462526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodistribution of boron concentration on melanoma-bearing hamsters after administration of p-, m-, o-boronophenylalanine.
    Hiratsuka J; Yoshino K; Kondoh H; Imajo Y; Mishima Y
    Jpn J Cancer Res; 2000 Apr; 91(4):446-50. PubMed ID: 10804294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Metabolically Stable Boron-Derived Tyrosine Serves as a Theranostic Agent for Positron Emission Tomography Guided Boron Neutron Capture Therapy.
    Li J; Shi Y; Zhang Z; Liu H; Lang L; Liu T; Chen X; Liu Z
    Bioconjug Chem; 2019 Nov; 30(11):2870-2878. PubMed ID: 31593447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental Studies of Boronophenylalanine ((10)BPA) Biodistribution for the Individual Application of Boron Neutron Capture Therapy (BNCT) for Malignant Melanoma Treatment.
    Carpano M; Perona M; Rodriguez C; Nievas S; Olivera M; Santa Cruz GA; Brandizzi D; Cabrini R; Pisarev M; Juvenal GJ; Dagrosa MA
    Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):344-52. PubMed ID: 26232853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Boron neutron capture therapy induces cell cycle arrest and DNA fragmentation in murine melanoma cells.
    Faião-Flores F; Coelho PR; Arruda-Neto J; Maria DA
    Appl Radiat Isot; 2011 Dec; 69(12):1741-4. PubMed ID: 21441034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis through Bcl-2/Bax and cleaved caspase up-regulation in melanoma treated by boron neutron capture therapy.
    Faião-Flores F; Coelho PR; Toledo Arruda-Neto JD; Maria-Engler SS; Tiago M; Capelozzi VL; Giorgi RR; Maria DA
    PLoS One; 2013; 8(3):e59639. PubMed ID: 23527236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor potential induction and free radicals production in melanoma cells by Boron Neutron Capture Therapy.
    Faião-Flores F; Coelho PR; Muniz RO; Souza GS; Arruda-Neto J; Maria DA
    Appl Radiat Isot; 2011 Dec; 69(12):1748-51. PubMed ID: 21620718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics in melanoma-bearing mice of 5-dihydroxyboryl-6-propyl-2-thiouracil (BPTU), a candidate compound for boron neutron capture therapy.
    Verrijk R; Smolders IJ; Huiskamp R; Gavin PR; Philipp KH; Begg AC
    Br J Cancer; 1994 Apr; 69(4):641-7. PubMed ID: 8142252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular accumulation of 18F-labelled boronophenylalanine depending on DNA synthesis and melanin incorporation: a double-tracer microautoradiographic study of B16 melanomas in vivo.
    Kubota R; Yamada S; Ishiwata K; Tada M; Ido T; Kubota K
    Br J Cancer; 1993 Apr; 67(4):701-5. PubMed ID: 8471428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo evaluation of o-carboranylalanine as a potential boron delivery agent for neutron capture therapy.
    Yong JH; Barth RF; Wyzlic IM; Soloway AH; Rotaru JH
    Anticancer Res; 1995; 15(5B):2033-8. PubMed ID: 8572598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo evaluation of carboranyl uridines as boron delivery agents for neutron capture therapy.
    Liu L; Barth RF; Tjarks W; Soloway AH; Anisuzzaman AK
    Anticancer Res; 1996; 16(1):113-20. PubMed ID: 8615595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy.
    Masunaga S; Sakurai Y; Suzuki M; Nagata K; Maruhashi A; Kinash Y; Ono K
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):920-7. PubMed ID: 15465210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a Novel Boron-Containing α-D-Mannopyranoside for BNCT.
    Tsurubuchi T; Shirakawa M; Kurosawa W; Matsumoto K; Ubagai R; Umishio H; Suga Y; Yamazaki J; Arakawa A; Maruyama Y; Seki T; Shibui Y; Yoshida F; Zaboronok A; Suzuki M; Sakurai Y; Tanaka H; Nakai K; Ishikawa E; Matsumura A
    Cells; 2020 May; 9(5):. PubMed ID: 32455737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced melanogenesis induced by tyrosinase gene-transfer increases boron-uptake and killing effect of boron neutron capture therapy for amelanotic melanoma.
    Tsuboi T; Kondoh H; Hiratsuka J; Mishima Y
    Pigment Cell Res; 1998 Oct; 11(5):275-82. PubMed ID: 9877098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Boron neutron capture therapy (BNCT) for malignant melanoma with special reference to absorbed doses to the normal skin and tumor.
    Fukuda H; Hiratsuka J; Kobayashi T; Sakurai Y; Yoshino K; Karashima H; Turu K; Araki K; Mishima Y; Ichihashi M
    Australas Phys Eng Sci Med; 2003 Sep; 26(3):97-103. PubMed ID: 14626847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of boron neutron capture therapy and external beam radiotherapy for brain tumors.
    Barth RF; Grecula JC; Yang W; Rotaru JH; Nawrocky M; Gupta N; Albertson BJ; Ferketich AK; Moeschberger ML; Coderre JA; Rofstad EK
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):267-77. PubMed ID: 14697448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular binding of carboranylalanine and some effects of boron neutron capture. Analysis of cultured melanoma B16 cells.
    Pettersson OA; Olsson P; Lindström P; Sjöberg S; Larsson BS; Carlsson J
    Acta Oncol; 1994; 33(6):685-91. PubMed ID: 7946449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward a clinical application of ex situ boron neutron capture therapy for lung tumors at the RA-3 reactor in Argentina.
    Farías RO; Garabalino MA; Ferraris S; Santa María J; Rovati O; Lange F; Trivillin VA; Monti Hughes A; Pozzi EC; Thorp SI; Curotto P; Miller ME; Santa Cruz GA; Bortolussi S; Altieri S; Portu AM; Saint Martin G; Schwint AE; González SJ
    Med Phys; 2015 Jul; 42(7):4161-73. PubMed ID: 26133616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.